Glypican-3-specific antibody and uses thereof
US9790267B2 · kind B2 · utility
10Cited by
44References
4Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Feb 17, 2014 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | Jun 22, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to compositions and methods for diagnosing and treating diseases, disorders or conditions associated with dysregulated expression of GPC3. The invention provides novel antibodies that specifically bind to glypican-3 (GPC3). The invention also relates to a fully human chimeric antigen receptor (CAR) wherein the CAR is able to target GPC3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.